Note the time zone of the Virtual Congress is Eastern Daylight Time (EDT, UTC-4)
Please use the arrow to scroll right for additional sessions
The viewing of sessions, cannot be accessed from this conference calendar. All sessions are accessible via the Virtual Platform
- JOHN L. LEDERER (United States of America)
- Louis Constine (United States of America)
- Navin Pinto (United States of America)
Session Description: This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC. With an ever-improving understanding of clinical and biological risk factors, treatment strategies for pediatric neuroblastoma have become more tailored based on risk stratification, predicted response, and risk of relapse. However, it is also important to consider treatment by compartmentalizing neuroblastoma and planning in concordance with the perspectives and goals of patients and their families. Join a panel of experts for an in-depth discussion of pediatric neuroblastoma and its treatment across the continuum of care, treatment of bone/bone-marrow and CNS/leptomeningeal metastases, and use of new and emerging prognostic and predictive markers. Experts will also discuss the need to integrate patient and family perspectives into treatment planning to improve outcomes and enhance treatment and side-effect monitoring.
- Susan Parsons (United States of America)
- Miguela Caniza (United States of America)
- Sadaf Altaf (Pakistan)
- Jaime Shalkow (Mexico)
- Israel Fernandez-Pineda (Spain)
- Rejin Kebudi (Turkey)
- Courtney E. Sullivan (United States of America)
- Sarah Cohen-Gogo (Canada)
- Cielle Wachnian (Canada)
- Stephen A. Sands (United States of America)
- Klaus Seiersen (Denmark)
- Guillaume Beldjoudi (France)
- Marie Bleakely (United States of America)
- Todd Cooper (United States of America)
- Sherif Kemal (Egypt)
- Scott Howard (United States of America)